Day: June 9, 2022

Profire Energy to Present Virtually and Host 1x1 Investor Meetings at the 12th Annual East Coast IDEAS Investor Conference on June 23rd

Profire Energy to Present Virtually and Host 1×1 Investor Meetings at the 12th Annual East Coast IDEAS Investor Conference on June 23rd

LINDON, Utah, June 09, 2022 (GLOBE NEWSWIRE) — Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the “Company”) that provides solutions which enhance the efficiency, safety, and reliability of industrial combustion appliances, today announced that Ryan Oviatt, Co-Chief Executive Officer and Chief Financial Officer, & Cameron Tidball, Co-Chief Executive Officer, will participate in the virtual East Coast IDEAS Investor Conference on June 23, 2022. The Company’s presentation and webcast is scheduled to be available at 6:00 am ET on June 22nd and will be accessible through the conference website: www.IDEASconferences.com. Anyone interested in participating or learning more about the IDEAS conferences should contact Steven Hooser at (214) 872-2710 or shooser@threepa.com. About Profire Energy, Inc. Profire...

Continue reading

Fortis Inc. Announces Redemption Price of Its 2.85% Senior Unsecured Notes Due December 12, 2023

Fortis Inc. Announces Redemption Price of Its 2.85% Senior Unsecured Notes Due December 12, 2023

Not for distribution to United States news wire services or dissemination in the United States. ST. JOHN’S, Newfoundland and Labrador, June 09, 2022 (GLOBE NEWSWIRE) — Fortis Inc. (TSX: FTS) (“Fortis” or the “Corporation”) announced today the redemption price for its outstanding 2.85% Senior Unsecured Notes due December 12, 2023 (the “Notes”). The redemption of all $500,000,000 aggregate principal amount of the Notes was announced by the Corporation on May 9, 2022 and is effective as of today (the “Redemption Date”). The redemption price is $1,013.977 per $1,000 principal amount of the Notes, which includes interest accrued to but excluding the Redemption Date in the amount of $13.977. The redemption price has been calculated in accordance with the terms of the base indenture...

Continue reading

Genmab Commences New Arbitration Under License Agreement With Janssen

Genmab Commences New Arbitration Under License Agreement With Janssen

Company Announcement COPENHAGEN, Denmark; June 9, 2022 – Genmab A/S (Nasdaq: GMAB) announced today that it has commenced a new arbitration under its license agreement with Janssen Biotech, Inc. (Janssen) for daratumumab. This new arbitration follows from the award in the prior arbitration, where the tribunal ruled in favor of Janssen on the question as to whether Genmab is required to share in Janssen’s royalty payments to Halozyme Therapeutics, Inc. for its technology used in the subcutaneous formulation of daratumumab (marketed as DARZALEX FASPRO® in the United States), cf. Company Announcement No 14. The tribunal based its ruling on the finding that DARZALEX FASPRO constitutes a new licensed product under the license agreement. In this new arbitration, Genmab is consequently seeking an award of $405 million plus interest in accrued...

Continue reading

Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Reporting its financial results and continued progress across short-acting psychedelics portfolio Executive team and IP position strengthened LONDON, June 09, 2022 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, has today published its financial results for the fiscal year ended February 28, 2022. A complete copy of the audited consolidated financial statements prepared in accordance with International Financial Reporting Standards and the corresponding management’s discussion and analysis can be found under the Company’s profile on SEDAR at www.sedar.com. Unless otherwise indicated, all currency references are in Canadian dollars.  Financial Highlights  Cash on hand as...

Continue reading

Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor

Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor

Third quarter revenue of $26.2 million declined sequentially and year over year due to the anticipated waning of COVID-19 volumes and the economic shutdowns in Asia Received approval from New York State Department of Health for its AMPIPROBE® HPV Molecular Diagnostic tests available on the GENFLEX® platform, as well as approvals on additional sample types around chlamydia, gonorrhea and trichomonas Appointed and hired several new executive management team members in the quarter to position the Company for continued growth Engaged world class investment bank to provide advisory services including the evaluation of strategic alternatives for the Company, its Enzo Clinical Lab and Enzo Life Sciences divisions and its various assets Enzo Life Sciences (ELS) revenue of $7.6 million in Q3 was consistent year over year and increased 9% on...

Continue reading

Chair and CEO Ann Hand Headlines Metaverse Panel at the Bloomberg Technology Summit

Chair and CEO Ann Hand Headlines Metaverse Panel at the Bloomberg Technology Summit

SANTA MONICA, Calif., June 09, 2022 (GLOBE NEWSWIRE) — Super League Gaming (Nasdaq: SLGG), a global leader in video game experiences and entertainment at the intersection of the creator economy, gameplay content and the metaverse, shared her expert thoughts and insights at the recent invite-only Bloomberg Technology Summit. The panel, entitled Gaming and the Metaverse – Real or Just Playing?, examined technological accelerations that are paving the way for a new phygital reality – particularly within gaming. Joining  Ms. Hand on the panel was Brad Oberwager, Executive Chair of Linden Lab.  The two leaders discussed the recent explosion of innovation in this space, and how the metaverse promises to blur the line between digital and physical. To view the entire panel discussion, please click HERE. Following the panel, Ms. Hand...

Continue reading

ETC Announces Fiscal 2022 Full Year and Fourth Quarter Results

ETC Announces Fiscal 2022 Full Year and Fourth Quarter Results

SOUTHAMPTON, Pa., June 09, 2022 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation (OTC Pink: ETCC) (“ETC” or the “Company”) today reported its financial results for the fifty-two week period ended February 25, 2022 (“fiscal 2022”) and the thirteen week period ended February 25, 2022 (the “2022 fourth quarter”). Robert L. Laurent, Jr., ETC’s Chief Executive Officer and President stated, “ETC’s fiscal 2022 results, though below historical levels, improved over the prior year, but those results were once again affected by worldwide travel restrictions that made sales activities challenging. Fiscal 2022 results reflect a net sales increase of 17.7%, gross profit increase of 241.6%, a 14 % reduction in operating expense and other income of $5.2 million, leading to a return to net income $1.8 million. We enter fiscal 2023 with significant...

Continue reading

Stitch Fix Announces Third Quarter Fiscal Year 2022 Financial Results

Stitch Fix Announces Third Quarter Fiscal Year 2022 Financial Results

SAN FRANCISCO, June 09, 2022 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal shopping and styling service, has released its financial results for the third quarter of fiscal year 2022 ended April 30, 2022. Stitch Fix CEO Elizabeth Spaulding said, “While third quarter top-line results, as well as active client counts, were largely within our expectations, we know we still have work to do. This quarter we made progress on improving the overall client experience in order to position Stitch Fix for profitable growth and value creation over time. We are encouraged by the activity we are seeing inside the expanded Stitch Fix ecosystem, including our sixth consecutive quarter of revenue per active client growth.” Spaulding added, “We strongly believe in our strategy of expanding our established Fix model...

Continue reading

Rent the Runway, Inc. Announces First Quarter 2022 Results

Rent the Runway, Inc. Announces First Quarter 2022 Results

Strong revenue momentum: Q1 2022 revenue up 100% year-over-year Achieves record ending Active Subscriber count Significant increase in Gross Margin to 34%, up 9 percentage points YoY NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) — Rent the Runway, Inc. (“Rent the Runway”) (NASDAQ: RENT), the world’s first and largest shared designer closet platform, today reported financial results for the fiscal quarter ended April 30, 2022. “I’m excited to share that we exceeded our Q1 guidance across all key metrics both on the top and bottom lines, growing revenue 100% YoY and gross margin by 9 points YoY. Our strong performance is evidence of our firm position in the broader experience economy, which has enabled us to make significant progress on our path to profitability and achieve record ending Active Subscribers in the first quarter of 2022,”...

Continue reading

Marel: Wenger acquisition successfully closed

Marel: Wenger acquisition successfully closed

Marel has successfully closed the USD 540 million acquisition of Wenger, a global leader in processing solutions for the high growth markets of pet food, plant-based proteins, and aqua feed. The two companies have a great strategic and cultural fit and a highly complementary product portfolio and geographic presence catering to customers’ rising demand for high-quality food and feed that is processed in a sustainable and affordable way. Transaction highlights Marel has successfully closed the USD 540 million acquisition of Wenger Manufacturing LLC, a global leader in processing solutions for the high growth markets of pet food, plant-based proteins, and aqua feed. The agreement to acquire Wenger, as announced on 27 April 2022, was subject to customary closing conditions which have been fully satisfied as of 9 June, such as anti-trust and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.